
Tests of ByHeart infant formula tied to a botulism outbreak that has sickened dozens of babies showed that all of the company's products may have been contaminated.
Laboratory tests of 36 samples of formula from three different lots showed that five samples contained the type of bacteria that can lead to the rare and potentially deadly illness, the company said Monday on its website.
“Based on these results, we cannot rule out the risk that all ByHeart formula across all product lots may have been contaminated,” the company wrote.
At least 31 babies in 15 states who consumed ByHeart formula have been sickened in the outbreak that began in August, according to federal and state health officials. In addition, other infants who drank ByHeart formula were treated for botulism in earlier months, as far back as November 2024, although they are not counted in the outbreak, officials said.
Clostridium botulinum type A, the type of bacteria detected, can be unevenly distributed in powdered formula. Not all babies who ingest it will become ill, though all infants under age 1 are at risk, medical experts said.
ByHeart recalled all of its formula nationwide on Nov. 11. However, some product has remained on store shelves despite the recall, according to state officials and the U.S. Food and Drug Administration.
Parents and caregivers should stop feeding the formula to babies immediately and monitor the children for symptoms, which can take up to 30 days to appear.
Infant botulism occurs when babies ingest spores that germinate in their intestine and produce a toxin. Symptoms include constipation, difficulty sucking or feeding, drooping eyelids, flat facial expression and weakness in the arms, legs and head. The illness is a medical emergency and requires immediate treatment.
At least 107 babies nationwide have been treated for botulism with an IV medication known as BabyBIG since Aug. 1, health officials said. In a typical year, less than 200 infants are treated for the illness.
To report an illness tied to the outbreak, contact an FDA consumer complaint coordinator or fill out an online MedWatch form.
Consumers who bought ByHeart on the company's website on or after Aug. 1 can receive a full refund, an expansion of its previous policy, the company said.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
LATEST POSTS
- 1
Amid growing bipartisan scrutiny of Pete Hegseth, Trump says he 'wouldn't have wanted … a second strike' on alleged Venezuelan drug boat survivors - 2
Viable Correspondence: Building Solid Connections - 3
Top 15 Web-based Entertainment Stages for Individual Marking - 4
Knesset FADC extends emergency draft for 280,000 IDF reservists until January 1 - 5
Santa's sleigh or the International Space Station? How to spot a bright Christmas flyby Dec. 24 and 25
Instructions to Keep up with Your Traded Teeth for Life span
Bayer sues COVID vaccine makers over mRNA technology
The Solution to Ecological Protection: Saving Nature for People in the future
7 Espresso Machines for Home Baristas
Illumina unveils dataset to speed up AI-powered drug discovery
Understanding the Rudiments of Tree Administrations
Find the Interesting Universe of Computerized reasoning: the Capability of man-made intelligence
New movies to watch this weekend: See 'Wake Up Dead Man: A Knives Out Mystery' in theaters, rent 'Bugonia,' stream 'Caught Stealing' on Netflix
Discovering a sense of harmony: Individual Accounts of Reflection and Care













